nicardipine has been researched along with Respiratory Insufficiency in 2 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Respiratory Insufficiency: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Pulmonary vascular response to the inhalation of various concentrations of oxygen (FIO2) was studied under basal conditions and after nicardipine in 10 patients with pulmonary hypertension secondary to chronic bronchitis." | 10.17 | [Acute effects of nicardipine on the vascular reactivity of oxygen in patients with respiratory insufficiency and pulmonary hypertension]. ( Lévy, S; Paganelli, F; Philip-Joët, F; Saadjian, A; Saadjian, M, 1993) |
"Pulmonary vascular response to the inhalation of various concentrations of oxygen (FIO2) was studied under basal conditions and after nicardipine in 10 patients with pulmonary hypertension secondary to chronic bronchitis." | 6.17 | [Acute effects of nicardipine on the vascular reactivity of oxygen in patients with respiratory insufficiency and pulmonary hypertension]. ( Lévy, S; Paganelli, F; Philip-Joët, F; Saadjian, A; Saadjian, M, 1993) |
"Nicardipine is an intravenously administered dihydropyridine calcium channel antagonist whose primary physiological action includes vasodilatation." | 1.29 | Nicardipine to control mean arterial pressure during extracorporeal membrane oxygenation. ( Lynch, A; Pietsch, JB; Tobias, JD, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saadjian, A | 1 |
Philip-Joët, F | 1 |
Paganelli, F | 1 |
Saadjian, M | 1 |
Lévy, S | 1 |
Tobias, JD | 1 |
Pietsch, JB | 1 |
Lynch, A | 1 |
1 review available for nicardipine and Respiratory Insufficiency
Article | Year |
---|---|
[Acute effects of nicardipine on the vascular reactivity of oxygen in patients with respiratory insufficiency and pulmonary hypertension].
Topics: Blood Gas Analysis; Clinical Protocols; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Nicardi | 1993 |
1 trial available for nicardipine and Respiratory Insufficiency
Article | Year |
---|---|
[Acute effects of nicardipine on the vascular reactivity of oxygen in patients with respiratory insufficiency and pulmonary hypertension].
Topics: Blood Gas Analysis; Clinical Protocols; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Nicardi | 1993 |
1 other study available for nicardipine and Respiratory Insufficiency
Article | Year |
---|---|
Nicardipine to control mean arterial pressure during extracorporeal membrane oxygenation.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Extracorporeal Membrane Oxygenati | 1996 |